Combipack of Ticagrelor Tablets IP 90 mg & Aspirin Gastro-Resistant Tablets IP 75 Mg – Tacobil AS Kit

Tacobil AS Kit: Combipack of Ticagrelor Tablets IP 90 mg & Aspirin Gastro-Resistant Tablets IP 75 Mg 
Composition – Combikit of Ticagrelor 90mg (14 Tablets) + Aspirin Gastro Resistant 75mg (7 Tablets)

Description:
The composition of Combipack of Ticagrelor Tablets IP 90 mg & Aspirin Gastro-Resistant Tablets IP 75 Mg is a fixed-dose combination pack designed for dual antiplatelet therapy (DAPT) in acute coronary syndromes (ACS) and post-PCI patients. Ticagrelor offers reversible and potent P2Y$_{12}$ inhibition, while Aspirin prevents thromboxane-mediated platelet aggregation. Together, they reduce atherothrombotic risk in high-risk cardiac patients.

KEY BENEFITS:
Synergistic Platelet Inhibition – Ticagrelor (P2Y$_{12}$ inhibitor) and Aspirin (COX-1 blocker) act via complementary mechanisms to prevent thrombus formation.
Reduced Risk of Recurrent Ischemic Events – Proven efficacy in lowering rates of MI, stroke, and cardiovascular death in ACS patients.
Convenient Fixed-Dose Kit – Simplifies dual therapy compliance with optimal dosing in a single daily-use pack.

Targeted specalists:
Gynecologists
Gastroenterologists
Infectious Disease Specialists

 Disclaimer:
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.